Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection (Q27480424)

2

0 references

R Iorio

3

0 references

A Vegnente

4

0 references

G Mieli-Vergani

5

0 references

D Vergani

Clinical and Experimental Immunology

6

0 references

publication date

June 1998

0 references

published in

0 references

volume

112

0 references

issue

3

0 references

page(s)

471-6

0 references

cites work

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Nonhepatic manifestations and combined diseases in HCV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

The natural course and heterogeneity of autoimmune-type chronic active hepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Non-organ specific autoantibodies in children with chronic hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Autoimmune hepatitis and/or hepatitis C: how to decide

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Interferon-induced chronic active hepatitis?

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

2 June 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00574.X

Virus-induced autoimmunity in hepatitis C virus infections: a rare event

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00574.X

Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00574.X

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00574.X

Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00574.X

Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Type II autoimmune hepatitis. What is the role of the hepatitis C virus?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904993

Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C

27 November 2018

1 reference

12 December 2020

The role of autoimmunity in hepatitis C infection

1 reference

12 December 2020

Meeting report: International Autoimmune Hepatitis Group

1 reference

12 December 2020

Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease

1 reference

12 December 2020

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

1 reference

12 December 2020

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

1 reference

12 December 2020

ANTINUCLEAR FACTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CONSIDERATION OF THE IMMUNOFLUORESCENT METHOD OF DETECTING ANTINUCLEAR ANTIBODIES, WITH RESULTS OBTAINED IN A FAMILY STUDY

1 reference

12 December 2020